Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: "Cost data for flibanserin is not provided. Some projection of cost should be available for any drug this far along in Phase III trials and for which the company has already begun marketing campaigns. If not from the company, then from stock analysts. The story properly quantifies the reportedbenefits in absolute terms which allows the reader to see that they are small. (Results aredescribed inQuality of Evidence comments.) Inaninterview a study researcher conceded that the absolute number of women reporting benefit was not large. The storyprovided statistics on common side effects includingdaytime sleepiness, dizziness, fatigue, anxiety, dry mouth, nausea and insomnia. These side effects resulted in 15% of thosetaking flibanserin vs 7% taking placebo withdrawing from the study. The story does a good job of presenting and evaluating the available evidence. Results are presented in absolute terms, for example that just under one third of women taking flibanserin reported improvement in sexual distress/desire compared to approximately one fifth of women taking placebo. In contrast,these results were presented in relative terms by the manufacturer. Except for the headline,"" 'Female Viagra' May Treat Low Sexual Desire"",this storyavoidsdisease mongeringand notes that""hypoactive sexual desire disorder"" in women is a controversial diagnosis. The text clarifies that while the popular press isdubbing flibanserin as the ""female Viagra"", it is not similar to Viagra or other drugs to treat erectile dysfunction. Conflicts of interest are disclosed. The story noted that the study researcherinterviewed is a paid consultant for the drug manufacturer. An alternative point of view is provided bytwo independent experts, apsychologist and a sex-therapist. The independent sources comment on the role that personal relationships play in sexual desire and experience which was not addressed or acknowledged by the researchers. The story indicates thatan alternative drug called the Intrinsa testosterone patchis available in Europe, but not in the U.S. The story also notes a difference betweenthese dugs; Intrinsais a hormonal treatment compared to flibanserin which is a non-hormonal. The story indirectly informs that reader that flibanserin is not available by noting that it is in phase III clinical trials and that the manufactureris seeking FDA approval (despite early direct to consumer marketing campaigns). The story makes it fairly clear that this is a new treatment also for a new and controversial diagnosis. The story was apparently based onresearch presented in abstract format the annual clinical meeting of the American College of Gynecologists and Obstetricians, although this informationhas not beenpublished in independently, peer-referred scientific journals. There is no direct evidence that it relied largely on a news release. In fact, the use of interviews with independent experts makes it clear that independent reporting took place." Claim: 'Female Viagra' May Treat Low Sexual Desire
[EX A]: "This story reports on a investigational drug, flibanserin, that is being developed to treat what is a controversial diagnosiscalled ""hypoactive sexual desire"" in women. The popular press has dubbed this drug ""Female Viagra"" despite that fact that it has few similarities to drugs that treat erectile dysfunction. Preliminary research examining the drug's efficacy in treating sexual distress and/or low sexual desire were presented at the May 2010 annual clinical meeting of the American College of Obstetricians and Gynecologists (ACOG). To place the story in context, previous reports from the manufacturerclaimed thatflibanserin resulted in""clinically significant""improvementin the number of sexually satisfying events reported by women taking the drug vs. those taking placebo, an absolute difference of 0.7 events per month. The story was detailed and did a good job of presentinginformation in absolute terms so that the reader could clearly see that reported benefits were small and of unknownclinical significance. Good reminders that this is a controversial diagnosis and that ""some experts see it as the medicalization of what is for many women a relationship issue."""

[EX Q]: Paragraph: The story doesn't specifically address costs, but it does discuss some of the most common types of fiber-rich food such as fruits, vegetables, legumes and whole grains. Given the diversity, and widespread availability, of these foods, we'll give this a Satisfactory rating. However, it would have been nice to see some acknowledgment that many people people particularly people with limited financial resources live in so-called "food deserts," which have little access to fresh produce, etc. The story discusses a wide range of benefits, ranging from reduced risk of heart disease to weight loss. But the focus of the story was on weight loss, so that's what we'll focus on here. The story refers to two studies, only one of which appears to have been published. The first study is an analysis of people who have used the MyFitnessPal app in an attempt to lose weight. In that case, users who came within 5 percent of their weight loss goal consumed an average of 29 percent more fiber than users who did not come close to their weight loss goals. The second study was actually published (in 2015), and compared weight loss across two groups of study participants who had metabolic syndrome. One group followed the American Heart Association's recommended diet, while the other was told only to eat 30 grams of fiber per day. Both groups ended up eating the same amount of fiber per day (19 grams), and both groups lost weight. At the end of a year, the AHA diet group lost more (an average of 5.6 pounds), but the second group still lost 4.6 pounds. Neither of these studies are in the mold of a conventional intervention/health-benefit paradigm. But then neither is specifically looking at either a precisely-defined intervention (such as a pharmaceutical trial) or a disease they're looking loosely defined dietary guidelines and weight loss (and while weight can be a risk factor, it is not an illness). Bearing that in mind, the story does a satisfactory job of quantifying the relevant benefits in each instance. In general, eating more fiber carries few potential harms. The primary risks are, as the Mayo Clinic notes, "adding too much fiber too quickly can promote intestinal gas, abdominal bloating and cramping." To minimize that risk, the Mayo Clinic urges people to "Increase fiber in your diet gradually over a period of a few weeks. This allows the natural bacteria in your digestive system to adjust to the change. Also, drink plenty of water. Fiber works best when it absorbs water." This story does not outline these harms specifically, which is too bad. But the story does tell readers that they should "add fiber slowly and with plenty of water." That's enough to rate this as Satisfactory (though it's clearly not ideal). The two studies, mentioned above under benefits, have some problems: It's not clear where the unpublished MyFitnessPal data come from or how they were analyzed; and the 2015 study was of only 240 volunteers. These limitations were not noted. Also,the story would have been much stronger if it had addressed one key question: Were there any differences between groups (in either study) in regard to their age, sex, or physical activity? Any of those factors could play a key role in differences in weight loss, and the story sheds no light there. A side note: As we mentioned above, this story discusses a wide range of other benefits associated with eating enough fiber, ranging from reduced risk of heart disease to reduced risk of diabetes. We mention this because the story links to relevant research supporting each of those claims. We applaud that. There is no overt disease mongering. But we did want to point out two things. The story states: "fiber may play an important role in that ever-elusive health goal, weight loss." First, while being obese may be a disease, simply being overweight is not. Second, many people who aspire to lose weight do so for reasons other than health (and aren't overweight in the first place). Those are important distinctions, and ones that this story doesn't make. The story quotes from a wide variety of sources, and clearly labels each source's affiliation. One issue that's not addressed in the story is the utility of fiber supplements. Are they good? Bad? Beneficial? Useless? The story doesn't offer any insight here. It would be useful for readers to know whether such supplements may be useful tools for meeting daily fiber intake goals. Foods that contain fiber have been around longer than humans have, so we'll rate this N/A. Dietary fiber isn't new, and the story doesn't claim that it is. We'll rate this N/A. The story doesn't appear to be based on a news release. (In fact, given that the story doesn't seem to draw on any particularly new studies, guidelines or other external drivers, we're kind of curious as to what spurred this story. We're suspecting a pitch from MyFitnessPal.) Claim: It's Comical. It's Critical. It Might Even Help You Lose Weight.
[EX A]: This story urges people to make sure they're eating enough dietary fiber, with a focus on fiber's role in promoting healthy weight loss. And, overall, it does a fairly good job though giving a high-profile to unpublished data from a privately-owned fitness app (MyFitnessPal) is a little unusual. To draw causal conclusions about a specific food/dietary component, without providing fulsome data is worrisome. Also, we're unaware of any studies at this point that speak to the veracity of MyFitnessPal dietary record keeping, and the accuracy of its collection is probably worth validating and exploringor at least noting its limitations. And, on a broader level, focusing on a single ingredient such as"fiber" feeds nutritionismthe notion that the presence or absence of a particular nutrient makes a food healthful or not. We don't have nutrition drilled down that specifically. This point would have made the story stronger. Fiberespecially from whole fruits and vegetablesis an important part of a healthy diet, with institutions from the Mayo Clinic to Harvard's T.H. Chan School of Public Health outlining the myriad ways that a fiber-rich diet reduces health risks. And, as this story notes, most people don't get enough fiber. Recommendations for daily intake of fiber vary, but tend to come in between 25 grams per day to 38 grams per day, depending on age and sex. A 2014 paper from USDA's Food Surveys Research Group found that Americans consume an average of 16 grams of fiber per day. Given the potential benefit of eating more fiber, this would seem like a conversation worth having. And that appears to be the goal of the story.

[EX Q]: Paragraph: The proposal outlined on Friday is the fourth iteration of the Metropolitan Area Projects (MAPS), a comprehensive capital improvement program first approved by city voters in 1993. The council is expected to consider a resolution on Tuesday that calls for a special election on Dec. 10. Funding in the MAPS 4 proposal includes $40 million for mental health and addiction services and $38 million for a family justice center offering services to victims of abuse. Another $50 million would be earmarked for affordable housing for the homeless. Claim: Oklahoma City mulls vote on MAPS 4 sales tax extension.
[EX A]:
The Oklahoma City council is expected to set a citywide vote for a one-cent sales tax that would generate nearly $980 million over eight years to fund dozens of city projects, including money for social services like mental health and homelessness.